Industry: Service & Software
Published Date: 2026-04-30
Pages: 130 Pages
Report ld: 6699255
Request Sample
Customized Report
Cell Immortalization Market Size(US$)

CAGR 2026-2032
5.9%
Market Size,2032
USD 5,461
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Cell Immortalization was estimated to be worth US$ 3642 million in 2025 and is projected to reach US$ 5461 million, growing at a CAGR of 5.9% from 2026 to 2032.
Cell immortalization refers to the biological process of enabling primary cells to exceed their inherent proliferative limits and gain unlimited division capacity through physical, chemical, or biological means. Normal somatic cells have a limited number of passages in vitro, while immortalization extends cell life and establishes stable cell lines by activating telomerase (e.g., hTERT gene transfection), inactivating tumor suppressor proteins (p53/Rb, such as HPV E6/E7 or SV40 large T antigen), or viral transformation (EBV). Immortalized cells can maintain their original differentiation characteristics and genotype for a long period and are widely used in fields such as tumor research, drug screening, vaccine production, and gene therapy. Representative immortalization technologies include telomerase overexpression, proto-oncogene induction, and spontaneous immortalization. This technology is one of the core tools for modern biomedical basic research and product development.
The global cell immortalization market and research are characterized by a pattern of technological leadership from Europe and the United States, and accelerated application and translation in the Asia-Pacific region. North America, as a leading birthplace, continues to innovate in CRISPR, iPSC reprogramming, and telomerase regulation technologies. Companies such as ATCC and Thermo Fisher provide standard immortalization kits and cell banks, widely used in target discovery and gene therapy. Europe has a deep foundation in tumor biology and mechanism research. ECACC and DSMZ have extremely high requirements for the traceability and ethical standards of immortalized cell lines, promoting the international circulation of high-quality cell resources. The Asia-Pacific region (China, Japan, and South Korea) is experiencing rapid growth in the development of novel immortalization vectors (lentiviruses, transposons) and the construction of industrialized cell lines, especially driven by CRO/CDMO and biosimilars, with strong demand for industrial-grade suspension-acclimated immortalized cell lines (such as HEK293 and CHO). Future trends include: conditional immortalization systems based on CRISPRa/i, non-transgenic transient immortalization technologies, and alternative methods that reduce the use of primary animals in accordance with the 3R principle. Obstacles: Immortification may alter the original cell phenotype; long-term passage leads to karyotype instability, and regulatory concerns about tumorigenicity increase the difficulty of review. Updates: FDA guidelines encourage the use of fully characterized immortalized cell lines to replace animal experiments; China's CDE has released guidelines for stable cell lines used in gene therapy products, and the industry is actively promoting animal-free immortalized reagents.
This report provides a comprehensive view of the global market for Cell Immortalization, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Cell Immortalization market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Cell Immortalization.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Cell Immortalization companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Cell Immortalization revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Cell Immortalization revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Cell Immortalization Product Introduction
1.2 Global Cell Immortalization Market Size Forecast (2021–2032)
1.3 Cell Immortalization Market Trends & Drivers
1.3.1 Cell Immortalization Industry Trends
1.3.2 Cell Immortalization Market Drivers & Opportunities
1.3.3 Cell Immortalization Market Challenges
1.3.4 Cell Immortalization Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cell Immortalization Players Revenue Ranking (2025)
2.2 Global Cell Immortalization Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Cell Immortalization Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Cell Immortalization
2.6 Cell Immortalization Market Competitive Analysis
2.6.1 Cell Immortalization Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Cell Immortalization Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cell Immortalization revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Cell Immortalization Market Classification
3.1 Introduction by Type
3.1.1 Stem Cell Therapy
3.1.2 Cell Transplantation
3.1.3 Drug Transport
3.1.4 Others
3.1.5 Global Cell Immortalization Sales Value by Type
3.1.5.1 Global Cell Immortalization Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Cell Immortalization Sales Value, by Type (2021–2032)
3.1.5.3 Global Cell Immortalization Sales Value, by Type (%), 2021–2032
3.2 Introduction by Cell Types
3.2.1 Human Cells
3.2.2 Mouse Cells
3.2.3 Non-mammal Cells
3.2.4 Others
3.2.5 Global Cell Immortalization Sales Value by Cell Types
3.2.5.1 Global Cell Immortalization Sales Value by Cell Types (2021 vs 2025 vs 2032)
3.2.5.2 Global Cell Immortalization Sales Value, by Cell Types (2021–2032)
3.2.5.3 Global Cell Immortalization Sales Value, by Cell Types (%), 2021–2032
3.3 Introduction by Doubling Time
3.3.1 >30h
3.3.2 24-30h
3.3.3 18-24h
3.3.4 <18h
3.3.5 Global Cell Immortalization Sales Value by Doubling Time
3.3.5.1 Global Cell Immortalization Sales Value by Doubling Time (2021 vs 2025 vs 2032)
3.3.5.2 Global Cell Immortalization Sales Value, by Doubling Time (2021–2032)
3.3.5.3 Global Cell Immortalization Sales Value, by Doubling Time (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biopharmaceutical Company
4.1.2 Research Laboratory
4.1.3 Hospital
4.1.4 Other
4.2 Global Cell Immortalization Sales Value by Application
4.2.1 Global Cell Immortalization Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Cell Immortalization Sales Value by Application (2021–2032)
4.2.3 Global Cell Immortalization Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Cell Immortalization Sales Value by Region
5.1.1 Global Cell Immortalization Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Cell Immortalization Sales Value by Region (2021–2026)
5.1.3 Global Cell Immortalization Sales Value by Region (2027–2032)
5.1.4 Global Cell Immortalization Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Cell Immortalization Sales Value, 2021–2032
5.2.2 North America Cell Immortalization Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Cell Immortalization Sales Value, 2021–2032
5.3.2 Europe Cell Immortalization Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Cell Immortalization Sales Value, 2021–2032
5.4.2 Asia Pacific Cell Immortalization Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Cell Immortalization Sales Value, 2021–2032
5.5.2 South America Cell Immortalization Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cell Immortalization Sales Value, 2021–2032
5.6.2 Middle East & Africa Cell Immortalization Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cell Immortalization Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Cell Immortalization Sales Value, 2021–2032
6.3 United States
6.3.1 United States Cell Immortalization Sales Value, 2021–2032
6.3.2 United States Cell Immortalization Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Cell Immortalization Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Cell Immortalization Sales Value, 2021–2032
6.4.2 Europe Cell Immortalization Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Cell Immortalization Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Cell Immortalization Sales Value, 2021–2032
6.5.2 China Cell Immortalization Sales Value by Type (%), 2025 vs 2032
6.5.3 China Cell Immortalization Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Cell Immortalization Sales Value, 2021–2032
6.6.2 Japan Cell Immortalization Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Cell Immortalization Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Cell Immortalization Sales Value, 2021–2032
6.7.2 South Korea Cell Immortalization Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Cell Immortalization Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Cell Immortalization Sales Value, 2021–2032
6.8.2 Southeast Asia Cell Immortalization Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Cell Immortalization Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Cell Immortalization Sales Value, 2021–2032
6.9.2 India Cell Immortalization Sales Value by Type (%), 2025 vs 2032
6.9.3 India Cell Immortalization Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Lonza
7.1.1 Lonza Profile
7.1.2 Lonza Main Business
7.1.3 Lonza Cell Immortalization Products, Services, and Solutions
7.1.4 Lonza Cell Immortalization Revenue (US$ Million), 2021–2026
7.1.5 Lonza Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Cell Immortalization Products, Services, and Solutions
7.2.4 Thermo Fisher Scientific Cell Immortalization Revenue (US$ Million), 2021–2026
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 JSR
7.3.1 JSR Profile
7.3.2 JSR Main Business
7.3.3 JSR Cell Immortalization Products, Services, and Solutions
7.3.4 JSR Cell Immortalization Revenue (US$ Million), 2021–2026
7.3.5 JSR Recent Developments
7.4 Sartorius
7.4.1 Sartorius Profile
7.4.2 Sartorius Main Business
7.4.3 Sartorius Cell Immortalization Products, Services, and Solutions
7.4.4 Sartorius Cell Immortalization Revenue (US$ Million), 2021–2026
7.4.5 Sartorius Recent Developments
7.5 Merck
7.5.1 Merck Profile
7.5.2 Merck Main Business
7.5.3 Merck Cell Immortalization Products, Services, and Solutions
7.5.4 Merck Cell Immortalization Revenue (US$ Million), 2021–2026
7.5.5 Merck Recent Developments
7.6 AcceGen
7.6.1 AcceGen Profile
7.6.2 AcceGen Main Business
7.6.3 AcceGen Cell Immortalization Products, Services, and Solutions
7.6.4 AcceGen Cell Immortalization Revenue (US$ Million), 2021–2026
7.6.5 AcceGen Recent Developments
7.7 Creative Biolabs
7.7.1 Creative Biolabs Profile
7.7.2 Creative Biolabs Main Business
7.7.3 Creative Biolabs Cell Immortalization Products, Services, and Solutions
7.7.4 Creative Biolabs Cell Immortalization Revenue (US$ Million), 2021–2026
7.7.5 Creative Biolabs Recent Developments
7.8 InSCREENex GmbH
7.8.1 InSCREENex GmbH Profile
7.8.2 InSCREENex GmbH Main Business
7.8.3 InSCREENex GmbH Cell Immortalization Products, Services, and Solutions
7.8.4 InSCREENex GmbH Cell Immortalization Revenue (US$ Million), 2021–2026
7.8.5 InSCREENex GmbH Recent Developments
7.9 BioIVT
7.9.1 BioIVT Profile
7.9.2 BioIVT Main Business
7.9.3 BioIVT Cell Immortalization Products, Services, and Solutions
7.9.4 BioIVT Cell Immortalization Revenue (US$ Million), 2021–2026
7.9.5 BioIVT Recent Developments
7.10 Krishgen Biosystems
7.10.1 Krishgen Biosystems Profile
7.10.2 Krishgen Biosystems Main Business
7.10.3 Krishgen Biosystems Cell Immortalization Products, Services, and Solutions
7.10.4 Krishgen Biosystems Cell Immortalization Revenue (US$ Million), 2021–2026
7.10.5 Krishgen Biosystems Recent Developments
7.11 Applied Biological Materials
7.11.1 Applied Biological Materials Profile
7.11.2 Applied Biological Materials Main Business
7.11.3 Applied Biological Materials Cell Immortalization Products, Services, and Solutions
7.11.4 Applied Biological Materials Cell Immortalization Revenue (US$ Million), 2021–2026
7.11.5 Applied Biological Materials Recent Developments
7.12 REPROCELL Inc
7.12.1 REPROCELL Inc Profile
7.12.2 REPROCELL Inc Main Business
7.12.3 REPROCELL Inc Cell Immortalization Products, Services, and Solutions
7.12.4 REPROCELL Inc Cell Immortalization Revenue (US$ Million), 2021–2026
7.12.5 REPROCELL Inc Recent Developments
7.13 FUJIFILM Wako Pure Chemical Corporation
7.13.1 FUJIFILM Wako Pure Chemical Corporation Profile
7.13.2 FUJIFILM Wako Pure Chemical Corporation Main Business
7.13.3 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Products, Services, and Solutions
7.13.4 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Revenue (US$ Million), 2021–2026
7.13.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments
7.14 Abace Biotechnology
7.14.1 Abace Biotechnology Profile
7.14.2 Abace Biotechnology Main Business
7.14.3 Abace Biotechnology Cell Immortalization Products, Services, and Solutions
7.14.4 Abace Biotechnology Cell Immortalization Revenue (US$ Million), 2021–2026
7.14.5 Abace Biotechnology Recent Developments
7.15 CELLCOOK
7.15.1 CELLCOOK Profile
7.15.2 CELLCOOK Main Business
7.15.3 CELLCOOK Cell Immortalization Products, Services, and Solutions
7.15.4 CELLCOOK Cell Immortalization Revenue (US$ Million), 2021–2026
7.15.5 CELLCOOK Recent Developments
7.16 Procell
7.16.1 Procell Profile
7.16.2 Procell Main Business
7.16.3 Procell Cell Immortalization Products, Services, and Solutions
7.16.4 Procell Cell Immortalization Revenue (US$ Million), 2021–2026
7.16.5 Procell Recent Developments
7.17 Takara Bio
7.17.1 Takara Bio Profile
7.17.2 Takara Bio Main Business
7.17.3 Takara Bio Cell Immortalization Products, Services, and Solutions
7.17.4 Takara Bio Cell Immortalization Revenue (US$ Million), 2021–2026
7.17.5 Takara Bio Recent Developments
7.18 Corning
7.18.1 Corning Profile
7.18.2 Corning Main Business
7.18.3 Corning Cell Immortalization Products, Services, and Solutions
7.18.4 Corning Cell Immortalization Revenue (US$ Million), 2021–2026
7.18.5 Corning Recent Developments
7.19 Evercyte
7.19.1 Evercyte Profile
7.19.2 Evercyte Main Business
7.19.3 Evercyte Cell Immortalization Products, Services, and Solutions
7.19.4 Evercyte Cell Immortalization Revenue (US$ Million), 2021–2026
7.19.5 Evercyte Recent Developments
8 Industry Chain Analysis
8.1 Cell Immortalization Value Chain
8.2 Cell Immortalization Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Cell Immortalization Sales Model
8.5.2 Sales Channels
8.5.3 Cell Immortalization Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Cell Immortalization market size was US$ 3642 million in 2025 and is forecast to reach a readjusted size of US$ 5461 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-04-30
Pages: 139
USD 4250.00
(Single User License)
The global Cell Immortalization market is projected to grow from US$ 3642 million in 2025 to US$ 5461 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-04-30
Pages: 159
USD 4900.00
(Single User License)
The global Cell Immortalization market was valued at US$ 3642 million in 2025 and is anticipated to reach US$ 5461 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-30
Pages: 126
USD 2900.00
(Single User License)
The global Cell Immortalization market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 107
USD 4250.00
(Single User License)
The global Cell Immortalization market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 149
USD 4900.00
(Single User License)
The global market for Cell Immortalization was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 131
USD 3950.00
(Single User License)
The global market for Cell Immortalization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-07
Pages: 93
USD 2900.00
(Single User License)
The global Cell Immortalization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-26
Pages: 90
USD 2900.00
(Single User License)
The global market for Cell Immortalization was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 127
USD 3950.00
(Single User License)
The global Cell Immortalization market size was US$ 3642 million in 2025 and is forecast to reach a readjusted size of US$ 5461 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-04-30
Pages: 139
The global Cell Immortalization market is projected to grow from US$ 3642 million in 2025 to US$ 5461 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-04-30
Pages: 159
The global Cell Immortalization market was valued at US$ 3642 million in 2025 and is anticipated to reach US$ 5461 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-30
Pages: 126
The global Cell Immortalization market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 107
The global Cell Immortalization market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 149
The global market for Cell Immortalization was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 131
The global market for Cell Immortalization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 93
The global Cell Immortalization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-26
Pages: 90
The global market for Cell Immortalization was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 127
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now